NASDAQ:ENSC

Ensysce Biosciences Stock Forecast, Price & News

$7.00

0.00 (0.00 %)

(As of 07/23/2021 12:00 AM ET)

Add

Compare

Today's Range

$6.39

▼

$7.10

50-Day Range N/A

52-Week Range

$6.39

▼

$23.99

Volume13,604 shs

Average Volume10,154 shs

Market Capitalization$43.54 million

P/E RatioN/A

Dividend YieldN/A

Beta-0.3

30 days | 90 days | 365 days | Advanced Chart

Receive ENSC News and Ratings via Email

Sign-up to receive the latest news and ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter.

About Ensysce Biosciences

Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is based in La Jolla, California.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ENSC
Previous Symbol
CUSIPN/A
CIKN/A
Webensysce.com
Phone858-263-4196
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash Flow$0.72 per share
Price / Cash Flow9.67
Book Value($0.19) per share
Price / Book-36.84

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares6,220,000
Market Cap$43.54 million
Next Earnings Date8/6/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.33 out of 5 stars

Medical Sector

1891st out of 2,214 stocks

Pharmaceutical Preparations Industry

778th out of 867 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Ensysce Biosciences.

0.0 Community Rank

Outperform Votes
Ensysce Biosciences has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Ensysce Biosciences has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Ensysce Biosciences and other stocks. Vote “Outperform” if you believe ENSC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ENSC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Ensysce Biosciences does not currently pay a dividend.
Dividend Growth
Ensysce Biosciences does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ensysce Biosciences insiders have not sold or bought any company stock.
Percentage Held by Insiders
39.60% of the stock of Ensysce Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
56.67% of the stock of Ensysce Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Ensysce Biosciences (NASDAQ:ENSC) Frequently Asked Questions

What stocks does MarketBeat like better than Ensysce Biosciences?

Wall Street analysts have given Ensysce Biosciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ensysce Biosciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Ensysce Biosciences' next earnings date?

Ensysce Biosciences is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Ensysce Biosciences.

Who are Ensysce Biosciences' key executives?

Ensysce Biosciences' management team includes the following people:

Dr. D. Lynn Kirkpatrick, CEO & Director (Age 64)
Mr. David C. Humphrey, Chief Financial Officer (Age 51)
Dr. Jeffrey Millard, Chief Operating Officer
Mr. Richard Wright M.B.A., MSE, Chief Bus. Officer
Mr. Geoff Birkett, Chief Commercial Officer
Dr. William K. Schmidt, Chief Medical Officer (Age 70)

Who are some of Ensysce Biosciences' key competitors?

Some companies that are related to Ensysce Biosciences include Satsuma Pharmaceuticals (STSA), Mereo BioPharma Group (MREO), PhaseBio Pharmaceuticals (PHAS), Cyclerion Therapeutics (CYCN), Synlogic (SYBX), Ardelyx (ARDX), Milestone Pharmaceuticals (MIST), scPharmaceuticals (SCPH), vTv Therapeutics (VTVT), Anebulo Pharmaceuticals (ANEB), Heat Biologics (HTBX), Novan (NOVN), Equillium (EQ), ContraFect (CFRX) and BioLineRx (BLRX).
View all of ENSC's competitors.

What is Ensysce Biosciences' stock symbol?

Ensysce Biosciences trades on the NASDAQ under the ticker symbol "ENSC."

How do I buy shares of Ensysce Biosciences?

Shares of ENSC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ensysce Biosciences' stock price today?

One share of ENSC stock can currently be purchased for approximately $7.00.

How much money does Ensysce Biosciences make?

Ensysce Biosciences has a market capitalization of $43.54 million.

What is Ensysce Biosciences' official website?

The official website for Ensysce Biosciences is ensysce.com.

Where are Ensysce Biosciences' headquarters?

Ensysce Biosciences is headquartered at 250 WEST 57 TH STREET SUITE 415, NEW YORK NY, 10107.

How can I contact Ensysce Biosciences?

Ensysce Biosciences' mailing address is 250 WEST 57 TH STREET SUITE 415, NEW YORK NY, 10107. The company can be reached via phone at 858-263-4196.

This page was last updated on 7/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Ensysce Biosciences Stock Forecast, Price & News

About Ensysce Biosciences

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth